Pfizer Resolves Trovan Litigation In Nigeria, But More Suits Remain
Executive Summary
Pfizer freed itself from the bulk of litigation over a 1996 Trovan clinical trial in Nigeria, agreeing to pay $75 million to settle civil and criminal charges brought by the Kano State government in Nigeria. The sum is a fraction of the more the $9 billion in claims the company was facing